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ABSTRACT
The microanatomy of immune clearance of infected brain cells remains poorly understood.
Immunological synapses are essential anatomical structures that channel information exchanges
between T cell–antigen-presenting cells (APC) during the priming and effector phases of T cells'
function, and during natural killer–target cell interactions. The hallmark of immunological synapses
established by T cells is the formation of the supramolecular activation clusters (SMACs), in which
adhesion molecules such as leukocyte function-associated antigen 1 segregate to the peripheral
domain of the immunological synapse (p-SMAC), which surrounds the T cell receptor–rich or central
SMAC (c-SMAC). The inability so far to detect SMAC formation in vivo has cast doubts on its
functional relevance. Herein, we demonstrate that the in vivo formation of SMAC at immunological
synapses between effector CD8+ T cells and target cells precedes and mediates clearance of virally
infected brain astrocytes.
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INTRODUCTION
Immunological synapses are thought to be the anatomical manifestation of intercellular
communication in the immune system (1). Immunological synapses serve as the anatomical
substrate of T cell–APC communication during the priming of naive T cells and during the effector
phase of T and NK cells' function (1–6). The molecular components of immunological synapses differ
between those established by T cells or NK cells. The essential feature of mature immunological
synapses formed by T cells is the distinctive “bull's eye” structure, (1, 3–6) a specialized intercellular
junction formed by the central supramolecular activation cluster (c-SMAC) containing TCR binding to
peptide-MHC, surrounded by a ring (peripheral SMAC [p-SMAC]) containing a high density of
adhesion molecules such as leukocyte function-associated antigen 1 (LFA-1), and intercellular
adhesion molecule 1 (ICAM-1) (1–8). LFA-1 is associated with Talin in the p-SMAC (6, 9) and activates
integrin signaling to link the immunological synapse and the cytoskeleton (7). So far, immunological
synapses have only been characterized in culture systems (1–8).
Homogeneous populations of antigen-specific T cells coincubated with epitope-loaded APCs in vitro
(6, 8–12) or with artificial planar bilayers (4, 13) have been examined either continuously over time,
using live cells imaged with a cooled charge-coupled device camera, or after fixation, using confocal
laser scanning microscopy to characterize the structure and kinetics of c- SMAC and p-SMAC at the
immunological synaptic interface.
T cell interactions with APCs are dynamic and formation of the mature immunological synapse is the
culmination of TCR activation. Immunological synapses are thought to facilitate TCR signaling by
concentrating TCRs binding to peptide-MHC. TCR activation stimulates a tyrosine kinase cascade that
results in Lck and ZAP-70 phosphorylation, rapid activation of phospholipase Cγ, generation of
inositol-polyphosphates, Ca2+ mobilization, and T cell activation (8, 10–12, 14) (for review see
reference 1).
However, the physiological relevance of immunological synapses has been challenged by kinetic
analyses that show a dissociation between synapse formation from effector function (15–17) and
the lack of evidence so far for their in vivo existence during immune responses in a living organism
(for a detailed discussion on the status of immunological synapses, see reference 1). Nevertheless,
very recent data demonstrate that one of the physiological functions of immunological synapses is to
direct cytokine secretion vectorially either directly into the synapse, or in a multidirectional manner
outside the synapse (18). This work illustrates how immunological synapses implement the vectorial
transfer of information, as neuronal synapses are known to do.
Here, we show that preceding and during the clearance of virally infected cells, effector CD8+ T cells
infiltrate specifically the brain area containing infected astrocytes. CD8+ T cells establish mature
immunological synapses composed of both the c- and p-SMAC. Immunological synapse formation
precedes the clearance of infected astrocytes. In CD8+ T cells contacting infected targets, tyrosine
kinases Lck and ZAP-70 became phosphorylated and polarized toward the synaptic interface, a result
of TCR activation that leads to T cell activation (8, 10–12, 14) (for review see references 1, 19).
Although previous in vivo studies failed to detect mature immunological synapses, our data
demonstrate the characteristic segregation of adhesion molecules, TCR, and signaling molecules
within effector T cells that adopt the typical structures of mature immunological synapses containing
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c- and p-SMAC. This proves their immunological significance during the clearance of infected cells in
a living organism.

RESULTS
Clearance of infected astrocytes from the brain
To visualize the detailed microanatomy of brain immunological synapses, we set up an experiment in
which T cells would selectively target virally infected brain astrocytes. To do so, nonreplicating
adenoviral vectors were chosen to infect brain cells within a restricted site within the rat brain (i.e.,
the striatum) and infected cells were identified through expression of a reporter gene encoded
within the vector (e.g., HSV1-thymidine kinase [TK]). More than 85% of infected cells were GFAPexpressing astrocytes (Fig. 1 A). 30 d later, animals were immunized with a systemic injection of RAdHPRT (20), an adenovirus encoding an unrelated transgene to that expressed in the brain, to
stimulate a specific systemic immune response against adenovirus. The systemic administration of
adenovirus is needed because the initial delivery of a nonreplicating adenovirus to the brain
parenchyma fails to prime a systemic immune response against adenovirus (or other infectious
antigens), as a result of the so-called immune privilege of the brain (20–23). A replication-deficient
adenovirus was used to avoid any interference from viral replication on cell viability. In this model,
cell loss is exclusively immune mediated, rather than as a result of viral replication.
Systemic immunization against adenovirus causes a specific infiltration of the brain injection site
with T cells, and clearance of TK-expressing astrocytes and adenoviral genomes from the striatum
(Figs. 1 B and and2).2). Astrocytes displayed MHC-I on their plasma membrane, thus constituting a
potential target for activated CD8+ T cells (24) (Fig. 1 C). Selective antibody depletion of CD4+ and
CD8+ T cells 3 d after the systemic immunization demonstrated that both were necessary for
astrocyte clearance (Fig. 3). That each type of T cell makes a separate contribution to clearance was
shown by the fact that CD4+ T cells remained confined to the perivascular compartment (Fig. 2),
whereas CD8+ T cells did infiltrate the site within the brain parenchyma proper where infected
astrocytes were located (Fig. 2). CD8+ T cells also established frequent close anatomical contacts
with infected brain cells (Fig. 2, c–f). CD8+ T cells' influx into the central nervous system (CNS)
reached its peak at 14 d after immunization, whereas the loss of infected cells occurred between 14
and 30 d (Figs. 1 and and3).3). The analysis of brain immunological synapses in vivo is based on the
detailed study of brains from 25 rats and a total of at least 60 immunological synapses that were
thoroughly studied in detail.
Initial stages in the formation of immunological synapses in vivo
Polarization of phosphorylated tyrosine kinases, the initial stages in the formation of immunological
synapses in vivo, can be detected preceding and throughout the clearance of infected astrocytes by
CD8+ T cells. To further characterize immune–target cell interactions and the activation of T cells, we
studied the distribution of phosphorylated Lck and ZAP-70 in CD8+ T cells contacting target
astrocytes. Engagement of the TCR on CD8+ T cells by MHC-I peptide complexes present on the
surface of target APCs activates effector T cells and stimulates the T cell tyrosine kinase signaling
cascade (10, 11, 14). Tyrosine kinase signaling activation was assessed by immunocytochemistry
3
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using antibodies recognizing specifically active, phosphorylated-Lck (p-Lck) (recognizing pY394), or
active, phosphorylated-ZAP-70 (p-ZAP-70) (recognizing pY319) (10, 11, 14, 25).
Phosphorylated-Lck and p-ZAP-70 were polarized in CD8+ T cells to sites of close membrane
apposition between CD8+ T cells and target astrocytes only in the virally injected hemisphere (Figs. 4
and and5).5). Phosphorylation of tyrosine kinases precedes the establishment of mature
immunological synapses. Thus, we studied the anatomical arrangements of these early sites of T
cell–astrocyte interactions through serial reconstruction appositions identified with the confocal
microscope, and three-dimensional artistic rendering of the confocal images (Figs. 4 B and 5 B). Most
CD8+ T cells displayed a single site of close membrane apposition with astrocytes (Fig. 4, A and B),
although in some cases a CD8+ T cell would make up to three such polarized contacts with a single
target astrocyte (Fig. 5). CD8+ T cells formed complex close interactions with target astrocytes. T
cells either surrounded the target cell's processes (Fig. 5 B [b, d, and e]) or displayed cytoplasmic
evaginations that appeared to press into the target cell body (Fig. 5 B [c, f, and g]). Thus, braininfiltrating CD8+ T cells increased TK cascade phosphorylation induced by TCR signaling (i.e., Lck and
ZAP-70), indicating that the CD8+ T cells were activated through interaction with antigenic peptides
on MHC-I expressed on astrocytes (Fig. 1 C). Polarization of phosphorylated TKs at contacts between
CD8+ T cells and target astrocytes strongly implied the visualization of immunological synapse
formation in progress.
SMAC formation during the maturation of immunological synapses in vivo
To determine whether mature immunological synapses containing c-SMAC and p-SMAC develop at
the CD8+ T cell–astrocyte junctions previously shown to contain polarized tyrosine kinases, we
studied the distribution of LFA-1 and TCR on T cells participating potentially in the formation of
immunological synapses; we used TK as a marker of virally infected cells. The analysis of LFA-1 and
TCR expression in T cells not in contact with infected cells showed a homogeneous, nonpolarized
distribution (Fig. 6). The distribution of LFA-1 and TCR at the T cell membrane closely apposed to
infected target astrocytes clearly indicated the formation of p-SMAC (LFA-1 rich, TCR poor) and cSMAC (LFA-1 poor, TCR rich) in vivo (Figs. 7 and and8).8). This indicates that T cell–astrocyte
junctions mature to form proper immunological synapses with SMAC formation, concomitantly with
the influx of CD8+ T cells into the brain, and preceding the clearance of virally infected astrocytes.
The optical images obtained with the confocal microscope were further analyzed using custommade three-dimensional reconstruction software. Images were α blended to perform a threedimensional reconstruction from the two-dimensional serial images. This model was rotated in three
dimensions, and reconstructions were used to examine in detail the microanatomy of mature brain
immunological synapses at the interface plane (Figs. 7–99).
At the interface plane, the p-SMAC is characterized by an LFA-1–immunoreactive ring (Figs. 7–99))
surrounding a central area of increased TCR immunoreactivity (Figs. 7–99)) and low or absent LFA-1
(Figs. 7, ,8,8, and and10).10). Note that in most cases LFA-1 immunoreactivity increases within the pSMAC (Fig. 10, D, G, and I), whereas in others there is a drop in c-SMAC LFA-1 (Fig. 10, F, H, and E);
both distributions provide a p-SMAC–rich/c-SMAC–poor LFA-1 pattern. Finally, in those T cells
forming mature immunological synapses, we observed that T cells' nuclei displayed a polarized notch
open toward the immunological synapse, indicating that the whole structure of T cells polarized
toward the immunological synapse (Fig. 8, A and E).
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DISCUSSION
In this study, we have shown that CD8+ T cells form typical immunological synapses in vivo
displaying p- and c-SMAC at the interface with virally infected astrocytes, preceding and during the
clearance of infected cells from the brain. We do so in a model of immune-mediated clearance of
infected astrocytes, and demonstrate that both CD8+ T cells and CD4+ T cells are necessary parts of
the effector arm of the immune response, possibly as CD4+ Th1 cells. However, detailed
morphological analysis demonstrated that CD4+ T cells remain circumscribed to the perivascular
compartment, whereas CD8+ T cells enter the brain parenchyma and form close anatomical contacts
with infected cells. A likely explanation is that CD4+ T cells may aid in the entry of CD8+ T cells into
the brain; this is similar to the strategies adopted by both CD4+ and CD8+ T cells during the
clearance of MHV from the brain (26).
Although both cell types peak at an early time point in the lymph nodes, it is likely that differential
chemokine and adhesion molecule expression by CD4+ T cells determines their delayed migration to
the CNS and their selective perivascular accumulation when compared with CD8+ T cells (27–30).
The delayed peak of intracranial CD4+ T cells may serve to facilitate the entry of macrophages into
the CNS (31).
Initial TCR activation leads to the specific stimulations of the TK signaling pathway; e.g.,
phosphorylated-Lck and phosphorylated-ZAP-70. These become polarized to areas of close
membrane apposition with target cells where mature immunological synapses will form later.
Membrane junctions between CD8+ T cells with target astrocytes display complex three-dimensional
morphology; at times, T cells' membranes completely surrounds individual processes of targetinfected cells, or even insinuate their cell body directly into the target astrocyte's soma.
Our experiments demonstrate that CD8+ T cells establish SMAC at immunological synapses with
infected brain astrocytes that express MHC-I. The data shown herein demonstrate that the mature
immunological synapses between T cells–APCs in vivo precede and mediate the clearing of virally
infected astrocytes. In addition, we determined that nuclei of T cells formed an open arch toward
the immunological synapse, a finding compatible with the known polarization of the microtubule
organization center and Golgi apparatus of T cells toward the immunological synapse (32).
The previous use of homogeneous populations of cloned T cells, APCs, and time-lapse confocal
microscopy has allowed the detailed characterization of the kinetics of T cell–APC interaction and
immunological synapse assembly and disassembly in culture (6, 8–12). Previous studies of T cell–APC
interactions during in vivo immune responses could not demonstrate the formation of p- and cSMAC, as the result of limited resolution of microscopical techniques used (25, 33). Multiphoton
laser scanning microscopy and confocal microscopy and other advanced imaging methodologies
have made major contributions to our dynamic understanding of T cell–APC interactions in lymph
nodes and other tissues in vivo (34). Although Kawakami et al. (33) used an ex vivo model to study
the influx into the spinal cord of antimyelin CD4+ T cells and McGavern et al. (25) studied entry of
CD8+ T cells into the meninges of lymphocytic choriomeningitis virus (LCMV)–infected animals, the
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anatomical resolution of these studies precluded the morphological identification of SMAC
formation in vivo (25, 33) (for a discussion on the status of visualization of immunological synapses
in vivo, see reference 1, Section 7, page 407).
That SMACs indeed form at immunological synapses during in vivo immune responses within the
brain parenchyma during clearing of viral infections has hereby been demonstrated. Even if potential
contacts between T cells and local APCs were described, the techniques used were unable to
demonstrate the existence of SMAC formation during natural immune responses in the brain in vivo
(1), thus not resolving the existence of SMAC formation as part of in vivo immunological synapse
formation.
We believe that the following factors aided in our capacity to detect SMAC formation in vivo in the
context of a model antiviral immune response. First, we used an established model in which the
kinetics of T cell influx contact with potential targets and elimination of transduced cells were all
characterized in much detail. This allowed us to look for formation of immunological synapses at the
time of peak T cell entry, but preceding the loss of transduced cells. Second, we used a replicationdefective virus expressing a marker gene. This allowed us to identify potential target cells by their
expression of a marker gene, without viral replication compromising the survival of infected cells.
Third, we optimized the perfusion of animals and our immunocytochemical protocol, in such a way
to achieve best preservation of cellular structures through careful perfusion of experimental
animals, and full and homogenous antibody penetration throughout the 50-μm-thick vibratome
section, through careful improvements to the immunocytochemical protocols used. This allowed us
to unravel the three-dimensional structure of interactions between T cells and the complex
morphology of target brain astrocytes, and uncover sites of membrane apposition that would not
have been found in thinner sections, or in the absence of complete antibody penetration. Fourth, we
studied simultaneously the distribution of the essential markers that characterize SMAC formation in
immunological synapses, and markers of the target cells, in combination within single sections using
four-color immunostaining. Finally, the custom-made three-dimensional reconstruction software for
confocal images allowed us to rotate cells in close anatomical appositions and observe the
distribution of the several markers at different optical planes in a way that provides a complete
picture of the distribution of immunological synaptic proteins in three full dimensions. This resulted
in the typical “bull's eye” images of the mature immunological synaptic interfaces illustrated in Fig.
8.
Although the functional consequences of molecular segregation in the immunological synapse
remain under investigation (16, 35), recent work has demonstrated that immunological synapses
serve to channel cytokines and effector molecules toward target cells (18, 36). That mature
immunological synapses were found in the brain preceding the clearance of viral infected cells,
suggests that the presence of SMAC-containing immunological synapses in a physiological context in
vivo may be necessary for clearance of virally infected cells to occur. However, the ultimate proof of
this hypothesis will have to wait the development of compounds that selectively inhibit
immunological synapse formation.
The demonstration of mature immunological synapses in vivo during antiviral immune responses will
allow further experimental exploration of immunological synaptic function during normal and
pathological immune responses in vivo. Furthermore, this work should help contribute to settling
6
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the controversy over the existence and functional significance of mature immunological synapses in
vivo during antiviral immune responses. In summary, we propose that mature, SMAC-containing
immunological synapses are the anatomical substrate that mediates the complex sequence of
activation and effector function of T cells in vivo, as CD8+ T cells clear virally infected cells from the
CNS.

MATERIALS AND METHODS
Animals, surgical procedures, viruses.
Adult male Sprague-Dawley rats (250 g body weight) (Charles River) were used according to CedarsSinai Medical Center's Institutional Animal Care and Use Committee–approved protocols.
Adenoviruses used in this study were first-generation E1/E3-deleted recombinant adenovirus
vectors based on adenovirus type 5. The construction of RAdTK (expressing herpes simplex virus
type I thymidine kinase, HSV1-TK) and RAdHPRT (expressing hypoxanthine-guanine phosphoribosyltransferase), all contain the hCMV promoter and have all been described in detail elsewhere (37).
Animals were injected unilaterally in the left striatum with 107 infectious units (i.u.) of RAdTK in a
volume of 1 μl and immunized 30 d later with 5 × 108 infectious units of RAdHPRT injected
subcutaneously. Animals were killed for analysis at different time points after immunization as
described in more detail in the following sections.
Role of CD4+ and CD8+ T cells in clearing of adenovirally infected cells from the brain.
75 animals were injected with 107 i.u. of RAdTK into the striatum at day 0. 1 mo later, rats were
anaesthetized briefly and immunized subcutaneously in the back with 100 μl of either sterile saline
(n = 15) or 5 × 108 i.u. of RAdHPRT (n = 60). 3 d after systemic immunization against adenovirus, one
group of animals (n = 15) was injected weekly with 0.5 mg of OX8 monoclonal antibody i.p. to
deplete CD8+ T cells. Another group (n = 15) was injected i.p. with 1 mg of OX34 monoclonal
antibody every 2 wk to deplete CD4+ T cells, and two groups of animals were injected with mouse
monoclonal irrelevant isotype antibodies as appropriate controls. The number of CD4+ and CD8+ T
cells were quantified in draining cervical lymph nodes (Fig. S1). Results of the depletion studies are
shown in Fig. 3. 7, 14, and 30 d after the immunization, five animals from each experimental group
were killed via anesthetic overdose, transcardially perfused with 200–500 ml of oxygenated Tyrode
solution, and spleen and cervical lymph nodes were removed for flow cytometry. Immediately
afterward, animals were perfused/fixed with 4% paraformaldehyde to fix the brain. Brains were
postfixed in 4% paraformaldehyde for up to 48 h, after which they were washed in phosphate buffer,
cut into smaller tissue pieces, and sectioned as described in the following paragraph. This procedure
provides excellent quality preservation of brain tissue for further analysis. For the CD8 depletion
studies, postfixed brains were sectioned on a vibratome (Leica Instruments) at 50-μm section
thickness. In the CD4 depletion studies, brains were cryoprotected in 20% sucrose and 16-μm
sections were cut on the cryostat (Leica Instruments).
Immunocytochemical procedures and confocal analysis.
50-μm coronal brain sections were cut serially through the striatum on a Leica vibratome, and
immunofluorescence or DAB detection was performed as described previously (20), using the
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following primary antibodies recognizing: CD8 (1:500, mouse, Serotec), CD4 (1:100, mouse, Serotec),
TK (1:10,000, rabbit, custom made), NeuN (1:1,000, mouse, Chemicon), GFAP (1:500, guinea pig,
Advanced Immunochemical), phosphorylated Lck (1:50, rabbit, Cell Signaling), LFA-1 (1:500, mouse,
IgG2a, BD Biosciences), TCR (1:100, mouse, IgG1, BD Biosciences), phosphorylated ZAP-70 (1:100,
rabbit, Cell Signaling), and MHC-I (1:1,000, mouse, Serotec). Sections were examined using a Leica
DMIRE2 confocal microscope (Leica Microsystems). Three-dimensional reconstructions to allow
rotation of the images were rendered with α-blending software (custom made by K. Wawrowsky).
Striatal sections from 25 animals were screened and analyzed in their whole extent searching for T
cells interactions; a total of at least 60 immunological synapses (a likely underestimation of the total
number of synapses present in the brain) at various stages of development were recorded and
analyzed in detail.
Note that given the complexity of the confocal analysis, the number of total immunological synapses
illustrated throughout the manuscript in detail demonstrates the existence of immunological
synapses in vivo, but obviously cannot be considered a faithful estimation of their total number.
Currently, it remains technically impossible to record accurately the exact number of mature
immunological synapses present in vivo.
To determine the approximate number of activated T cells over the total number of T cells, the
expression of phosphorylated ZAP-70, a marker of T cell activation after TCR engagement, and thus,
a close surrogate of potential immunological synaptic engagement, was quantified. This analysis
indicated that 75.4% of all CD8+ T cells within the injected striatum express phosphorylated ZAP-70.
This provides a quantitative estimate of the potential frequency of immunological synapses being
established by T cells.
Confocal analysis.
The brain sections were examined using a Leica DMIRE2 confocal microscope with the 63x oil
objective and Confocal Software (Leica Microsystems). A series range for each section was
determined by setting an upper and lower threshold using the Z/Y Position for Spatial Image Series
setting, and confocal microscope settings were established and maintained by Leica and local
technicians for optimal resolution. Contacts were defined as areas where colocalization of both
markers occurs between two cells in at least two 0.5-μm-thick optical sections. Contacts can also be
illustrated as they appear throughout the stack of sections as a simple 0.5-μm layer or as a
transparency of all layers merged together. Relative fluorescence intensity along the plane of the
immunological synaptic interface was measured with the Leica confocal software and is illustrated in
the figures with corresponding arrows traversing the measured optical planes.
Three-dimensional reconstructions where generated with a custom-made software. Images were αblended to perform a three-dimensional reconstruction from the two-dimensional serial images. The
images were rotated in three-dimensional perspective to get the optical plane of the interface. The
criteria of choosing the interface are illustrated in detail in Fig. 9. Artistic renderings (made by C.
Barcia) were produced based on the three- dimensional analysis for Figs. 4 B and 5 B.
Neutralizing antibody assay.
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Adenovirus neutralizing antibody titers were measured in serum samples as described by us (20, 38)
(Fig. S1).
Real-time quantitative PCR analysis.
12 rats were injected bilaterally into the striatum with 107 infectious units of RAdTK. 1 mo later, six
animals were control immunized with saline, and six animals were immunized intradermally with
RAdHPRT. Rats were killed 60 d after the immunization by neck dislocation and decapitation, after
an anesthetic overdose. Brains were removed, cut into five blocks (left and right forebrain, left and
right midbrain, and cerebellum), snap frozen in liquid nitrogen, and stored at −80°C. Frozen blocks of
the left or right forebrain (containing the striatum) were ground to a fine powder under liquid
nitrogen. DNA was extracted from 50 mg of ground tissue using spin columns for DNA purification
(QIAGEN). 250 ng of DNA, or a quantity of cDNA corresponding to 100 ng of total RNA was amplified
by PCR using TKf 5′-CGAGCCGATGAC TTACTGGC-3′ and TKr 5′-CCCCGGCGGATATCTCAC-3′ primers
and the FAM-labeled TKp 5′-TACACCCAACACCGCCTCGACC-3′ TaqMan probe (PerkinElmer). RNA
control was performed using two primers and a VIC-labeled 18S ribosomal probe (PerkinElmer). The
TK copy number standard curve was obtained using dilutions of the previously described EpTK
plasmid. The final concentration was 0.2 μM for each primer, probe 0.2 μM, dNTP 0.2 mM (except
for dUTP 0.4mM), MgCl2 5 mM, UNG 0.5U in PCR buffer in the presence of 1.25 U of AmpliTaq Gold
polymerase (PCR core reagents, PerkinElmer). DNA determinations were made in triplicate.
Amplifications used a ABI Prism 7700 sequence detection system (PerkinElmer) with an initial step at
50°C for 2 min, 95°C for 10 min, followed by 40 cycles of the following: denaturation at 95°C for 15 s
and annealing/extension at 60°C for 1 min. Raw data were analyzed using the SDS v1.6.3. software
(PerkinElmer).
Statistical analysis.
Viability data were expressed as mean ± SEM and evaluated by two- or one-way analysis of variance
(followed by Dunnet or Tukey multiple comparisons tests). Differences were considered significant if
P < 0.05. When significance testing using analysis of variance was not applicable, the Kruskal-Wallis
nonparametric test was used instead.
Online supplemental material.
Fig. S1 illustrates neutralizing antiadenoviral antibody titers in immunized and nonimmunized rats,
and levels of CD4+ and CD8+ T cells in cervical lymph nodes of naive and immunized rats. Fig. S2
illustrates the effects of specific depleting antibodies on levels of CD8+ and CD4+ T cells in the
spleen. The supplemental Materials and methods section includes detailed descriptions of
immunocytochemistry and its stereological quantification. Online supplemental material is available
at http://www.jem.org/cgi/content/full/jem.20060420/DC1.
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FIGURE LEGENDS
FIGURE 1: The systemic immune response clears infected astrocytes and virus genomes from the
brain. (A) Virally infected cells are astrocytes. To determine the cellular nature of infected cells,
confocal microscopy of triple immunolabeling of TK, a marker of adenovirus infection (green); GFAP,
an astrocyte marker (magenta); and NeuN, a neuronal marker (red), was performed in 50-μm thick
vibratome sections from the brains of animals studied 30 d after intracranial injection of virus, in the
absence or presence, of systemic immunization. The top row illustrates TK, GFAP, and the merging of
both images as indicated. The vast majority of the TK-immunoreactive cells were also GFAP+ (i.e.,
>85%). Some of the cells expressing both markers are indicated by white arrows on all three panels
(all the TK-immunoreactive cells illustrated in these panels also expressed GFAP). The bottom row
shows the same field, but colocalization was studied between TK and NeuN; no colocalization was
detected. This indicates that the virus used expresses its marker gene almost exclusively within
astrocytes, but not neurons. Bar, 100 μm. (B) Systemic immunization induces an immune response
that clears virally infected expressing astrocytes and viral genomes from the brain. Panels a–e
illustrate that after the systemic immunization against adenovirus, the adaptive immune response
clears virally infected cells from the striatum. Analysis of brain sections from immunized animals (c,
low power, and d, high power) show a reduction in the expression of the virally encoded marker
gene, TK, when compared with naive animals (a and b). The decrease in the number of infected cells
after immunization was assessed by quantifying adenovirally infected, TK-expressing cells (e), and
the decrease in the number of viral genomes was quantified using quantitative real-time TaqMan
PCR (f). Decreases in the number of infected cells (e), and adenoviral genomes (f), after the systemic
immunization against adenovirus was statistically significant (*, P < 0.05; Student's t test). This
indicates that the systemic immune response clears transduced astrocytes and viral genomes from
the brain. Bars, 1 mm. (C) Adenovirally infected astrocytes express MHC-I. These panels illustrate a
GFAP-immunoreactive astrocyte that has been infected with adenovirus and thus is immunopositive
for the marker protein TK, expressing MHC-I. Bar, 40 μm.
FIGURE 2: Anatomical localization of brain CD4+ and CD8+ T cells during the clearing of virally
infected cells. CD4+ T cells within the brain remained immediately adjacent to brain blood vessels in
the striatum (a and b), whereas CD8+ T cells (red) infiltrated the brain parenchyma proper (c and d).
Time course studies (see Fig. 3) indicated that peak brain numbers of T cells were reached at 30 d for
CD4+ T cells (b), and at 14 d for CD8+ T cells (d). Panels e and f illustrate that brain-infiltrating CD8+ T
cells (red) within the rat striatum 7 and 14 d after immunization concentrate within the immediate
vicinity of virally infected cells (i.e., TK-expressing cells *green+). Bars, 100 μm. CD8+ T cells establish
close intercellular contacts with virally infected cells. CD8+ T cells were found surrounding virally
infected (TK expressing) brain cells establishing multiple close contacts with them, especially at 14 d
after immunization. Here, we illustrate two examples taken at 14 d after immunization. e and f
represent confocal images throughout the thickness of the brain sections. Boxed areas in e and f are
shown magnified to the right, but only a single 0.5-μm-thick optical section through the stacks
shown in e and f is shown to demonstrate the close anatomical apposition between both cell types;
xz and yz side views are illustrated too. White arrows indicate areas of close anatomical apposition
of CD8+ T cells and infected no or very few brain cells. No or very few brain parenchyma–infiltrating
T cells were detected in the hemisphere not infected with adenovirus or in the brains of injected
animals that had not been immunized. Bar, 25 μm.
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FIGURE 3: CD4+ and CD8+ T cells are necessary for viral clearance from the brain. (A) CD4+ T cells are
necessary for clearance of virally infected cells from the brain parenchyma. There was no loss of
virally infected cells in animals in which CD4+ T cells had been depleted during the systemic
immunization against adenovirus (panel a; CD4+ T cells depleted rats: immunized + CD4-depleting
monoclonal antibody OX34. Control nondepleted rats: immunized animals + control nonimmune
antibody isotype). A peak in the number of CD4+ T cells within the striatum was detected at 30 d
after immunization in nondepleted immunized animals, but not in immunized rats depleted of
CD4+ T cells (b). As shown in Fig. 2, CD4+ T cells remained close to brain blood vessels. *, P < 0.05
compared with nondepleted controls (nonparametric Kruskal-Wallis). (B) CD8+ T cells are necessary
for clearance of virally infected cells from the brain parenchyma. No loss of virally infected cells
could be detected in animals in which CD8+ T cells had been depleted during the systemic
immunization against adenovirus (a; CD8+ T cell–depleted rats: immunized + CD8-depleting
monoclonal antibody OX8. Control nondepleted rats: immunized animals + control nonimmune
antibody isotype). A peak in the number of CD8+ T cells entering the brain parenchyma was detected
at 14 d after immunization in nondepleted immunized animals, but not in immunized rats depleted
of CD8+ T cells (b). As shown in Fig. 2, CD8+ T cells enter in the brain parenchyma proper and
establish close appositions with virally infected cells. *, P < 0.05 compared with nondepleted
controls (nonparametric Kruskal-Wallis). Rats that were injected with adenovirus in the brain, but
were neither immunized nor injected with antibodies, were used as further controls and are
illustrated in B. Notice that levels of infected, TK-immunoreactive cells in these animals did not differ
from T cell–depleted rats (a).
FIGURE 4: Polarized expression of p-Lck and p-ZAP-70 in CD8+ T cells tightly apposed to astrocytes
during clearance of virally infected cells from the brain. Animals were infected unilaterally in the
striatum with an adenovirus, and 30 d later they were immunized against adenovirus systemically.
The systemic immunization induces a selective infiltration of CD8+ T cells into the injected, but not
contralateral, hemisphere, which eventually clears infected astrocytes and viral genomes. All images
shown represent 0.5-μm-thick confocal optical sections. Panels in A illustrate an activated
lymphocyte in close anatomical apposition of the process of an astrocyte. Activation was established
by p-Lck (green) immunoreactivity (a) within CD8+ (red) lymphocytes (b). Only CD8+ T cells that
contacted astrocytes directly (GFAP+ processes) were immunoreactive for p-Lck, indicating the
selective activation of T cells (a and b). White arrows indicate that the CD8+ T cell is contacting a
GFAP-immunoreactive process (magenta) (c and merged images). DAPI nuclear staining (blue) was
used as a cellular counterstain. Minimal T cells were observed within the noninjected hemisphere
(not depicted). P-Lck within the CD8+T cells was polarized to the T cell's membrane in close contact
with the astrocyte's process (white arrow in merged images). B represents a three-dimensional
reconstruction of the contact illustrated in A; the confocal image of the contact area is shown in a; b
illustrates the color scales for A and B, including colors of areas of overlap between fluorophores. C
illustrates the polarized expression of phosphorylated ZAP-70 in several CD8+ T cells during the
clearance of infected GFAP+ astrocytes from the brain; p-ZAP-70 (green), CD8 (red), GFAP (magenta
or white), and DAPI (nuclear marker in blue). Note that ZAP-70 is polarized to the site of contact
between the CD8+ T cell and the astrocytes' processes. Bars, 15 μm.
FIGURE 5: Multiple sites of polarized accumulation of p-Lck in a CD8+ T cell establishing several
contacts with a target astrocyte. (A) Confocal images of a CD8+ T cell that displays three areas of
close membrane apposition to an astrocyte. (a–c) A stack of sections representing approximately a
15

Barcia C et al.
PubMed ID: 16923851
total of 20 μm. (a) The immunoreactivity of the CD8+ T cell for p-Lck indicating three areas of p-Lck
polarization (white arrows 1, 2, and 3 in a). b illustrates CD8-immunoreactivity and c shows the
immunoreactivity of the target astrocyte for GFAP. The merged image (d) represents a single 0.5-μm
optical section in which all three individual channels shown in a–c have been merged, with the
associated xz and yz lateral views, to illustrate two intercellular contacts that are indicated by the
white arrows labeled 1 and 2. Bar, 25 μm (B) The three-dimensional reconstruction, in detail, of the
immunological synapses shown in A. (a) The merged image of the three individual stacks shown
individually in A. Panel a has been rotated ∼35° to the left to clarify the view of two of the close
appositions; these have been reconstructed in three dimensions and are shown at higher
magnification in b–g. Within the three-dimensional reconstruction, the location of two close
contacts is indicated by the broken circles 1 and 2. Close contact 1 is shown in b, d, and e in more
detail. Panel b is the contact 1 of the three-dimensional reconstruction, from which a slice of the
image has been removed to demonstrate the polarization of p-Lck (green) to the area of close
apposition between both cells. Notice how the CD8+ T cell appears to engulf the GFAP process
(magenta). An enlarged confocal image of the close contact is illustrated in d, whereas e is a contour
map of each of the immunoreactivities illustrated in d. Panels c, f, and g illustrate the same analysis
for contact number 2. Notice how the CD8+ T cell appears to form protrusions into the GFAP process
of the astrocyte (magenta) (c, f, and g).
FIGURE 6: Homogenous distribution of LFA-1 and TCR immunoreactivity along the plasma
membrane of T cells not in contact with infected target cells.LFA-1 and TCR show homogeneous
distribution along the plasma membrane of T cells neither in close apposition of target infected cells,
nor involved in the formation of immunological synapses. Top panels (A–E) show a LFA-1 positive cell
(B) not in contact with a TK-immunoreactive process (D), showing a uniform distribution of LFA-1.
Panels F-J show a T cell with no LFA-1 expression (G) with a homogeneous distribution of TCR (H).
Panels K-O show a T cell expressing LFA-1 (L) and TCR (M) not contacting a TK positive cell (N)
showing no specific polarization and distribution in clusters. Panels P–T illustrate a CD8+ T cell
expressing LFA-1 in a nonpolarized fashion in a cell that does not contact any infected cell. Bar, 25
μm.
FIGURE 7: Formation of c-SMAC and p-SMAC in vivo. TCR polarization and clustering within cSMAC (A) and LFA-1 distribution to the p-SMAC (B). TCR staining is polarized to membrane areas
displaying close contacts between T cells and infected brain cells, and clusters at sites where
immunological synapses form (two different immunological synapses are shown in A and C). Threedimensional reconstructions allow visualization of the formation of c-SMAC at the interface of
lymphocytes and infected cells (A, under “Interface”); the quantification of the clustering of the TCR
at the c-SMAC of the immunological synapses shownin A is illustrated in C (yellow arrow and
intensity graph). LFA-1 forms a ring (p-SMAC) that surrounds c-SMAC, but is reduced within c-SMAC
itself (two different immunological synapses are shown in B and D). Three-dimensional
reconstructions show the LFA-1 immunoreactive p-SMAC ring at the interface between the T cells
and target infected brain cells (B, under “Interface”); the quantification of the distribution of LFA-1
immunoreactivity at the p-SMAC of immunological synapses shown in B is illustrated in D (yellow
arrow and intensity graph). Bars, 25 μm.
FIGURE 8: SMAC formation at immunological synapses in vivo, between T cells and infected
astrocytes in the brain. Two mature immunological synapses displaying typical and characteristic
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SMAC formations, are shown in A and B. The row of upper panels in A and B illustrate images
captured in the given channels, from left to right: DAPI (blue), LFA-1 (red), TCR (green), LFA1+TCR,
LFA1+TCR+DAPI (MERGE 1), the virally infected cell (TK; in white), and LFA1+TCR+DAPI+TK (MERGE
2). Notice that these mature immunological synapses are characterized by the specific distribution of
LFA-1 and TCR contacting the virally infected cell. In the views shown in the top panels (side views of
the immunological synapses), LFA-1 immunoreactivity displays high relative fluorescence density
within areas of the membrane lateral to the close apposition of membranes of the lymphocyte with
the infected cell, thus displaying the typical central region of lower density (see arrows in red
channel) at the site of highest density of immunoreactivity for TCR (see arrows in the green channel
and in the MERGE 1 and 2 images). The yellow asterisk indicates, in the white channel, the
anatomical location of the T cell. The row of bottom panels in A and B illustrate, respectively, low (a)
and high (b) magnifications of the close apposition between the T cell and the infected cell. These
images were reconstructed using three-dimensional visualization software to illustrate the
characteristic structure of the p-SMAC (LFA-1 ring) and c-SMAC (TCR cluster) at the interface of the
immunological synapses seen in en face views (c and d). To produce the three-dimensional image of
the interface shown in c and d, the three-dimensional reconstruction was rotated so that the plane
of the interface of the immunological synapse (b, broken arrow) could be observed from above
(white arrow in b shows the angle of vision of c and d). At the interface, typical “bull's eye”
structures, characteristic of p-SMAC (LFA-1 outer ring) and c-SMAC (central TCR cluster) can be
clearly recognized (c and d). In C, the intensity of fluorescence (I) was measured at the interface
(yellow line) of the immunological synapse in a 0.5-μm confocal layer taken through the interface.
The small graphs to the right of each synapse show the relative intensity values of fluorescence of
LFA-1 (in red) and TCR (in green). Note the maximum of intensity for LFA-1 was in the periphery of
the synapse (p-SMAC), whereas the TCR is clustered toward the center (c-SMAC). (D) A diagrammatic
view of a T cell contacting an antigen-expressing astrocyte illustrating the localization of molecules
involved in the immunological synapse and the polarization and phosphorylation of key tyrosine
kinases. (E) A characteristic activated T cell nucleus displaying the polarized arched conformation
opening toward the immunological synaptic interface. Bars, 15 μm.
FIGURE 9: Criteria used in the selection of optical planes from three-dimensional reconstructions
of mature immunological synapses, for the illustration of SMAC formation in vivo. 90° rotations of
three-dimensional reconstructions were made to observe the xz optical planes 1, 2, and 3 through
axis y. Images A1, A2, and A3 show xz optical planes from image A. The immunological synaptic
interface seen in optical plane xz (1) is illustrated in A1; this optical plane was selected as the one in
which the T cell's nucleus could not be visualized. Optical planes 2 and 3 (illustrated in A2 and A3)
show the T cell's nucleus, demonstrating that these optical planes are at a distance from the synaptic
interface and thus do not allow observation of the SMAC. Note that the optical plane 1 is the only
one that shows the SMAC. yz optical planes 4, 5, and 6 were obtained from a 90° rotation of image B
through the x axis. In plane 5 (illustrated in A5) the TCR is closely apposed to the infected cell
without any intervening LFA-1; this plane is taken through the center of the c-SMAC. In images of
planes 4 and 6 (illustrated in A4 and A6) LFA-1 immunoreactivity, rather than TCR, is in close
apposition of the infected cell, indicating that these planes are taken through the p-SMAC. Note that
this detailed three-dimensional reconstruction analysis was performed on the synapse illustrated in
Fig. 8 A.
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FIGURE 10: Quantitative distribution of LFA-1 through the plasma membrane of T cells involved in
formation of mature immunological synapses. The relative fluorescence of LFA-1 was measured in
six T cells forming mature immunological synapses contacting virally infected cells (A). The red LFA-1
channel was selected [B] and the complete distribution of LFA-1 throughout the extent of the plasma
membrane was delineated measuring the intensity of fluorescence in a linear graph (illustrated
schematically in C). Panels D–I show the quantification of LFA-1 in six different cells forming mature
immunological synapses. Small white arrows ‘1’ and ‘3’ indicate the p-SMAC and arrow ‘2’ the cSMAC. Note that the level of LFA-1 is reduced (or absent) within the c-SMAC of all cells. Further LFA1 levels are increased in the p-SMAC in some cells (illustrated in D, G, and I), while it does not
increase in the p-SMAC of others [F, H, E]. Note that for clarity the target virally infected cells, found
in apposition of the immunological synapses illustrated, are not shown; synapses shown in (D) and
(E) are illustrated in further detail in Fig. 7, and synapse (F) in Fig. 8 A. Synapses H, G, and I are not
illustrated further.

18

Barcia C et al.
PubMed ID: 16923851
FIGURE 1
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FIGURE 2
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FIGURE 3
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FIGURE 4
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FIGURE 5
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FIGURE 6
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FIGURE 7
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FIGURE 8
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FIGURE 9
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FIGURE 10
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SUPPLEMENTARY MATERIAL
SUPPLEMENTAL METHODS
Immunofluorescence.
Immunocytochemical detection methods were optimized during preliminary experiments to achieve
full and homogenous antibody penetration throughout the total thickness of vibratome sections.
Adjacent 50-μm thick sections of each brain were pretreated with citrate buffer during 30 min at
60°C to increase antigen retrieval and penetration of the antibodies into the tissues. Sections were
blocked with 1% Triton X-100 for 5 min and 3% normal horse serum in 0.1 M PBS, pH 7.4, for 60 min.
The sections were incubated at room temperature for 48 h with primary antibodies combined. In the
double or triple staining, the incubation with primary antibody was followed by 4 h of incubation
with the appropriate secondary antibodies. Alexa 488–conjugated goat anti–rabbit antibody
1:1,000; Invitrogen), Alexa 594-conjugated goat anti–rat IgG antibody (1:1,000; Invitrogen), Alexa
594–conjugated goat anti–mouse IgG antibody (1:1,000; Invitrogen), Alexa 647–conjugated goat
anti–guinea pig IgG antibody (1:1,000; Invitrogen), RRX goat anti–mouse IgG2a (1:500; Jackson
ImmunoResearch Laboratories) or FITC-goat anti–mouse IgG1 (1:500; Jackson ImmunoResearch
Laboratories). After washing, sections were incubated with DAPI solution for 30 min. Sections were
washed, mounted, and examined with a microscopy for normal fluorescence (Carl Zeiss
MicroImaging, Inc.) and analyzed with the confocal microscope (Leica).
DAB detection of immunocytochemistry.
Serial sections were used to detect transgene expression. Endogenous peroxidase activity was
quenched with 0.3% H2O2 in PBS, nonspecific Fc binding sites were blocked with 10% horse serum,
and sections were incubated for 48 h at room temperature with primary antibody diluted in PBS
containing 1% horse serum and 0.5% Triton-X-100 (antibody solution). Sections were incubated for 4
h with biotin-conjugated appropriate secondary antibodies (DakoCytomation). Antibody binding was
detected using avidin-biotin peroxidase with diaminobenzidine as chromogen, the glucose-oxidase
system as a generator of H2O2, and intensification with Ni. These sections were mounted on
gelatinized glass slides and were dehydrated before coverslipping.
Quantification of immunohistochemical staining.
Quantitative image analysis to estimate numbers of TK-, CD8+-, and CD4+-immunoreactive cells
were performed with specific stereology software (StereoInvestigator) using a computer-assisted
image analysis system with a Zeiss microscope connected to a digital camera through a zoom set
(Carl Zeiss MicroImaging, Inc.), as described by us previously (39). The stereological estimation of the
number of CD8 and TK immunoreactive cells was performed in the striatum and external capsule
overlying the striatum, and anatomical locations were identified according to the atlas of the rat
brain in 50-μm brain sections spaced at regular 250-μm intervals, as described in detail by us
previously (Dewey, R.A., G. Morrissey, C.M. Cowsill, D. Stone, F. Bolognani, N.J. Dodd, T.D.
Southgate, D. Klatzmann, H. Lassmann, M.G. Castro, and P.R. Lowenstein. 1999. Nat. Med. 5:1256–
1263; Suwelack, D., A. Hurtado-Lorenzo, E. Millan, V. Gonzalez Nicolini, K. Wawrowsky, P.
Lowenstein, and M.G. Castro. 2004. Gene Ther. 11:1742–1752). The estimation of the number of
cells was performed using the principle of the optical fractionator. The number of cells was
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measured in 200-μm-sided dissectors covering the whole surface area of the analyzed regions (50
counting frames in each section). Results were expressed as absolute number of positive cells in the
anatomical regions analyzed. Data are expressed as the means ± SEM.
SUPPLEMENTAL FIGURE LEGENDS
FIGURE S1. Systemic immunization against adenovirus increases the circulating titer of neutralizing
antibodies against adenovirus and increases the number of CD4+ and CD8+ T cells in cervical lymph
nodes draining from the brain. To demonstrate the presence of neutralizing antibodies against
adenovirus after systemic immunization against adenovirus, antibody titers were measured in two
different groups of immunized animals (either treated with OX8 antibody or treated with control
irrelevant antibody isotype). Both these groups of animals, but not naive, nonimmunized animals
(A), showed a significant increase in levels of circulating antiadenovirus antibodies. We observed an
increase in the numbers of CD4+ and CD8+ T cells (detected by flow cytometry) in cervical lymph
nodes in animals that had been injected with adenovirus into the brain and immunized systemically
against adenovirus, compared with control animals that had been injected with virus in the brain,
but had not been immunized (B and C). *, P < 0.05, Student’s t test.
FIGURE S2. Verification of systemic depletion of CD4+ and CD8+ T cells in animals injected with the
respective depleting antibodies. A statistically significant reduction of CD8+ T cells (A) or CD4+ T cells
(B) was observed, by flow cytometry, in the spleens of animals depleted of either CD8+ T cells,
through administration of OX8, or depleted of CD4+ T cells, through administration of OX34,
respectively. *, P < 0.05 was the value for the statistical significance of the difference between
immunized and depleted animals, compared with controls (nonparametric Kruskal-Wallis).
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SUPPLEMENTAL FIGURES
FIGURE S1

FIGURE S2
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